ERBB2 and breast cancer: For instance, UCNPs doped with radioactive 90Y and conjugated to the HER2-targeting toxin DARPin-PE40 have demonstrated approximately 2200-fold enhanced synergistic cytotoxicity in HER2-positive BC cells 207.